Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ultragenyx Pharmaceutical

27.20
-2.0300-6.94%
Pre-market: 27.460.2600+0.96%08:23 EDT
Volume:4.77M
Turnover:131.44M
Market Cap:2.57B
PE:-4.63
High:29.36
Open:29.34
Low:26.85
Close:29.23
Loading ...
May 05, 2022

Major Issues Report

8-K - Current report
Apr 22, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Major Issues Report

8-K - Current report
Jan 10, 2022

Major Issues Report

8-K - Current report
Jan 07, 2022

Major Issues Report

8-K - Current report
Nov 03, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2021

Major Issues Report

8-K - Current report
Oct 26, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Oct 07, 2021

Major Issues Report

8-K - Current report
Sep 27, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 03, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2021

Major Issues Report

8-K - Current report
Jun 30, 2021

Major Issues Report

8-K - Current report